tumor tissue CGP test
PGDx elio™ solutions
A proven portfolio of RUO and IVD kits powered by robust proprietary bioinformatics
PGDx elio SOLUTIONS
Decentralizing
comprehensive
genomic profiling
Our automated bioinformatics delivers >99% sensitivity and specificity1 with a seamless sample-to-answer workflow and optimized user experience.
We continuously optimize our portfolio of precision oncology solutions while also adding new clinically-relevant biomarkers and insights as they emerge. Our proprietary platform is well validated and can consistently identify hard-to-detect biomarkers, like MSI and TMB, with a high degree of accuracy.
Our distributed model facilitates in-house precision oncology to bring it closer to patients and empower labs with full control over data and specimens. We’ve honed our end-to-end workflow, from library preparation through result, to make local CGP testing simpler than ever.
PGDx elio SOLUTIONS
Powered by robust bioinformatics
Remove variability in NGS data
Our best-in-class software is the first of its kind to ever receive FDA clearance. We’ve optimized our bioinformatics pipeline with the most extensive training data. We leverage machine learning to automatically curate the data and eliminate the need for visual inspection while delivering unparalleled analytic power.
- 100x more high-quality training data powers FDA cleared software
- Qualified on Sanger sequencing and other orthogonal methods to ensure accuracy
- Identified biomarkers with >99% sensitivity and specificity1
Intuitive sample-to-answer solution
PGDx elio bioinformatics offers an easy-to-use interface that makes it simple to rapidly transform raw NGS data into user-ready reports. Our turn-key solution, developed using high-quality training data, expert curation, and machine learning algorithms, can quickly identify cancer mutations and empower every lab to provide timely and trustworthy results.
- Multiple file types put you in control of your data
- Sequencing-to-report workflow requires no human intervention
- Easy for any lab to adopt and scale for your growing business and increased molecular testing demand
Integrates easily into your workflow
We offer professional services to develop middleware, allowing report annotation and migration of discrete data into existing lab and medical record systems and databases. Flexible data file types and streamlined interoperability capabilities make incorporating PGDx elio into your workflow as painless as possible.
- Easily integrate data into your internal systems
- Annotate reports with our easy-to-use tools
- Enable the generation of custom reports (RUO only)
1. Wood et al. A machine learning approach for somatic mutation discovery. 2018. Sci Transl Med. 10(457). pii: eaar7939. doi: 10.1126/scitranslmed.aar7939.
NGS CLINICAL WORKFLOW
Where our solutions fit in
Innovating throughout the NGS workflow
From extracted DNA to automatically generated reports, PGDx has developed methods to optimize protocols and results. That helps make best-in-class CGP analysis accessible for any lab.
THE FIRST AND ONLY FDA CLEARED AND CE-IVD MARKED COMPREHENSIVE KITTED SOLUTION WITH BIOINFORMATICS
Maximize understanding of solid tumor biology with PGDx elio tissue complete
Quickly access comprehensive tumor insights and help guide personalized treatment decisions for your patients with our FDA cleared and CE-IVD marked test that delivers clinically significant results and enables new potential paths to reimbursement.
KITTED SOLUTIONS, READY FOR YOUR LAB
PGDx elio panels
Pan solid tumor profiling and biomarker solutions
GET STARTED
Open the door to precision medicine
PGDx elio Products
Biopharma Services
Stay Connected
Contact Us
Resources